Skandinaviska Enskilda Banken (SEB)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
39,389
-111,519
| -74% | -$3.68M | 0.01% | 626 |
|
|
2025
Q1 | $6.06M | Sell |
150,908
-31,218
| -17% | -$1.25M | 0.03% | 374 |
|
|
2024
Q4 | $8.59M | Buy |
182,126
+26,332
| +17% | +$1.24M | 0.04% | 318 |
|
|
2024
Q3 | $8.22M | Hold |
155,794
| – | – | 0.04% | 305 |
|
|
2024
Q2 | $8.44M | Hold |
155,794
| – | – | 0.04% | 287 |
|
|
2024
Q1 | $10.9M | Buy |
155,794
+126,348
| +429% | +$8.85M | 0.05% | 257 |
|
|
2023
Q4 | $2.46M | Sell |
29,446
-21,695
| -42% | -$1.81M | 0.01% | 536 |
|
|
2023
Q3 | $1.51M | Hold |
51,141
| – | – | 0.01% | 605 |
|
|
2023
Q2 | $1.67M | Buy |
51,141
+5,028
| +11% | +$164K | 0.01% | 593 |
|
|
2023
Q1 | $1.62M | Sell |
46,113
-2,238
| -5% | -$78.8K | 0.01% | 593 |
|
|
2022
Q4 | $2.22M | Sell |
48,351
-2,801
| -5% | -$128K | 0.02% | 515 |
|
|
2022
Q3 | $2.48M | Sell |
51,152
-7,949
| -13% | -$385K | 0.02% | 491 |
|
|
2022
Q2 | $2.32M | Hold |
59,101
| – | – | 0.02% | 534 |
|
|
2022
Q1 | $2.18M | Hold |
59,101
| – | – | 0.01% | 607 |
|
|
2021
Q4 | $2.7M | Hold |
59,101
| – | – | 0.01% | 577 |
|
|
2021
Q3 | $2.11M | Buy |
+59,101
| New | +$2.11M | 0.01% | 633 |
|